Paper3374545
An assessment of clinically useful measures of the consequences of treatment.
Laupacis A and 2 others. N Engl J Med, 1988. Cited by 1,302 papers, by iCite.
Cite this record
ConductScience Library. An assessment of clinically useful measures of the consequences of treatment. Papers, record 3374545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3374545
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Therapeutics | Major topic |
| Decision Making | |
| Evaluation Studies as Topic | |
| Humans | |
| Hypertension | |
| Models, Theoretical | |
| Probability | |
| Research Design | |
| Risk Factors |
Source PubMed
Cited by372
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,302 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42842543 | Barriers to entry: A participatory science study of tick identification, monitoring, and physical barriers to reduce tick bites on horses. | PLoS One | 2026 | https://conductscience.org/library/papers/42842543 | PubMed |
| 42736431 | Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial. | Nat Cancer | 2026 | https://conductscience.org/library/papers/42736431 | PubMed |
| 42610008 | Adjuvant Systemic Therapy in Melanoma: Relative versus absolute benefit; the number needed to treat (NNT) versus the number needed to harm (NNH)? | EJC Skin Cancer | 2024 | https://conductscience.org/library/papers/42610008 | PubMed |
| 42529811 | Estimated cardiac deaths associated with treating chronic lymphocytic leukemia with ibrutinib versus zanubrutinib in the United States. | Future Oncol | 2026 | https://conductscience.org/library/papers/42529811 | PubMed |
| 42479429 | Modeling Oxygen Saturation Targets, Mortality, and Retinopathy Among Extremely Preterm Infants. | JAMA Netw Open | 2026 | https://conductscience.org/library/papers/42479429 | PubMed |
| 42422471 | Metabolic health and cardiovascular outcomes in treated hypertension: a secondary analysis of SPRINT. | Clin Hypertens | 2026 | https://conductscience.org/library/papers/42422471 | PubMed |
| 42285001 | Strengths and pitfalls of NNT and NNH in early breast cancer escalation trials. | Breast | 2026 | https://conductscience.org/library/papers/42285001 | PubMed |
| 42265664 | Cholecystectomy versus conservative management for patients with uncomplicated symptomatic gallstones and cholecystitis: an updated systematic review and meta-analysis. | BMC Surg | 2026 | https://conductscience.org/library/papers/42265664 | PubMed |
| 42043470 | Diagnostic Utility of Digital Single-Operator Cholangioscopy for Risk-Enriched Detection and Surveillance of Intraductal Neoplasms of the Bile Duct: SPY-SCREEN Study (with Videos). | Dig Dis Sci | 2026 | https://conductscience.org/library/papers/42043470 | PubMed |
| 41953374 | Number Needed to Teach (N2T2): Bringing Additional Context to the Evaluation of CME Outcomes. | J CME | 2026 | https://conductscience.org/library/papers/41953374 | PubMed |
| 41938766 | Veterinarians' brief guide to confidence intervals, standardized effect size, and number needed to treat: understanding the impact of treatments and disease. | Front Vet Sci | 2026 | https://conductscience.org/library/papers/41938766 | PubMed |
| 41923457 | Using Propensity Score Weighting With Clustered Data When the Treatment Is Applied at the Level of the Cluster and Outcomes Are Assessed at the Level of the Individual: The Observational Analog of Cluster Randomization Trials. | Stat Med | 2026 | https://conductscience.org/library/papers/41923457 | PubMed |
| 41922901 | Ethanol infusion of the vein of marshall-based strategies for persistent atrial fibrillation: a systematic review and meta-analysis of randomized trials. | Europace | 2026 | https://conductscience.org/library/papers/41922901 | PubMed |
| 41858174 | Diminishing returns of disease-modifying treatment in older participants of multiple sclerosis clinical trials. | Mult Scler | 2026 | https://conductscience.org/library/papers/41858174 | PubMed |
| 41821806 | Preventing acute diverticulitis. any roles for non-absorbable antibiotics? in search of evidence: a systematic review, meta-analysis, and trial sequential analysis. | Front Gastroenterol (Lausanne) | 2023 | https://conductscience.org/library/papers/41821806 | PubMed |
| 41674449 | Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design. | Circulation | 2026 | https://conductscience.org/library/papers/41674449 | PubMed |
| 41618895 | Number needed to treat to avoid progression and death and cost analysis: zanubrutinib versus acalabrutinib in relapsed/refractory chronic lymphocytic leukemia. | Future Oncol | 2026 | https://conductscience.org/library/papers/41618895 | PubMed |
| 41536959 | Outcomes of catheter ablation for ventr tachycardia in structural heart disease: a meta-analysis and quality appraisal of trials. | Eur Heart J Open | 2026 | https://conductscience.org/library/papers/41536959 | PubMed |
| 41450534 | Effects of Intravenous Subanesthetic-Dose Esketamine on Early Postoperative Pain in Elderly Patients Undergoing Thoracoscopic Lung Surgery: A Randomized Double-Blind Controlled Trial. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/41450534 | PubMed |
| 41313171 | Smartphone-Based Approach-Avoidance Bias Modification Training for Depression: Randomized Clinical Trial. | JMIR Mhealth Uhealth | 2025 | https://conductscience.org/library/papers/41313171 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3374545
GET https://conductscience.org/api/papers/v1/3374545/cited_by?page=2